Processing

Please wait...

Settings

Settings

Goto Application

1. WO1999057141 - IMMUNODIAGNOSTIC REAGENT FOR THE DETECTION OF MAEDI-VISNA VIRUS AND CAEV INFECTION

Publication Number WO/1999/057141
Publication Date 11.11.1999
International Application No. PCT/EP1999/002810
International Filing Date 26.04.1999
Chapter 2 Demand Filed 22.11.1999
IPC
C07K 14/155 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
005from viruses
08RNA viruses
15Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
155Lentiviridae, e.g. human immunodeficiency virus (HIV), visna-maedi virus, equine infectious anaemia virus
G01N 33/531 2006.01
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48Biological material, e.g. blood, urine; Haemocytometers
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53Immunoassay; Biospecific binding assay; Materials therefor
531Production of immunochemical test materials
G01N 33/569 2006.01
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48Biological material, e.g. blood, urine; Haemocytometers
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53Immunoassay; Biospecific binding assay; Materials therefor
569for microorganisms, e.g. protozoa, bacteria, viruses
CPC
C07K 14/005
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
005from viruses
C12N 2740/15022
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
2740Reverse Transcribing RNA Viruses
00011Reverse Transcribing RNA Viruses
10011Retroviridae
15011Lentivirus, not HIV, e.g. FIV, SIV
15022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
G01N 33/531
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
48Biological material, e.g. blood, urine
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53Immunoassay; Biospecific binding assay; Materials therefor
531Production of immunochemical test materials
G01N 33/56988
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
48Biological material, e.g. blood, urine
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53Immunoassay; Biospecific binding assay; Materials therefor
569for microorganisms, e.g. protozoa, bacteria, viruses
56983Viruses
56988AIDS or HTLV
Applicants
  • INNOGENETICS N.V. [BE]/[BE] (AllExceptUS)
  • GONZALEZ, Lorenzo [ES]/[GB] (UsOnly)
  • TOLARI, Francesco [IT]/[IT] (UsOnly)
  • WATT, Neil [GB]/[GB] (UsOnly)
  • HARKISS, Gordon [GB]/[GB] (UsOnly)
  • AMORENA, Beatriz [ES]/[ES] (UsOnly)
  • SAMAN, Eric [BE]/[BE] (UsOnly)
  • VAN EYNDE, Geertrui [BE]/[BE] (UsOnly)
  • BADIOLA DIEZ, Juan José [ES]/[ES] (UsOnly)
  • EXTRAMIANA, Belén [ES]/[ES] (UsOnly)
  • BOLLO, Enrico [IT]/[IT] (UsOnly)
  • JUSTE, Ramon, A. [ES]/[ES] (UsOnly)
Inventors
  • GONZALEZ, Lorenzo
  • TOLARI, Francesco
  • WATT, Neil
  • HARKISS, Gordon
  • AMORENA, Beatriz
  • SAMAN, Eric
  • VAN EYNDE, Geertrui
  • BADIOLA DIEZ, Juan José
  • EXTRAMIANA, Belén
  • BOLLO, Enrico
  • JUSTE, Ramon, A.
Priority Data
98870101.730.04.1998EP
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) IMMUNODIAGNOSTIC REAGENT FOR THE DETECTION OF MAEDI-VISNA VIRUS AND CAEV INFECTION
(FR) REACTIF D'IMMUNODIAGNOSTIC POUR LA DETECTION D'UNE INFECTION PAR LE VIRUS MAEDI-VISNA ET LE VIRUS ARTHRITE-ENCEPHALITE CAPRINE
Abstract
(EN)
The current invention relates to a biotinylated peptide represented by the following formula: [B1 -L1] - (a) - CWHYX9X10YC- (b) - [L2- B2] (SEQ ID NO 83) wherein B represents a biotinyl moiety and L represents an amide bond or an amino acid linker sequence containing from 1 to 5 amino acid residues, with either [B1 -L1] or [L2 -B2] present or both, and wherein (a) represents from none to the maximum number of contiguous amino acids located from position 1 to position 4 in the sequence represented by SEQ ID NO 12, and wherein (b) represents from none to the maximum number of contiguous amino acids located from position 13 to position 18 in the sequence represented by SEQ ID NO 12.
(FR)
L'invention concerne un peptide biotinylé représenté par la formule générale [B1 -L1] - (a) - CWHYX9X10YC- (b) - [L2- B2] (identificateur de séquence SEQ ID N° 83), dans laquelle B est une fraction biotiynle et L est une liaison amide ou une séquence de liaison d'acides aminés contenant entre 1 et 5 résidus d'acides aminés, avec la présence de [B1 -L1] ou de [L2- B2] ou des deux à la fois. Par ailleurs, dans ladite formule, (a) est un nombre d'acides aminés contigus allant de zéro au maximum, ces résidus ayant un emplacement qui va de la position 1 à la position 4 dans la séquence représentée par l'identificateur de séquence SEQ ID N° 12, et (b) est un nombre d'acides aminés contigus allant de zéro au maximum, ces résidus ayant un emplacement qui va de la position 13 à la position 18 dans la séquence représentée par l'identificateur de séquence SEQ ID N° 12.
Latest bibliographic data on file with the International Bureau